Introduction: Glaucoma is one of the major causes of irreversible blindness worldwide. The vision loss here is related to elevated intraocular pressure (IOP) mediated degeneration of the optic nerve. Obstruction to aqueous humour outflow is the main reason for increased IOP and the two major types of glaucoma based on this include primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG). Current strategies are directed against reducing IOP, but progression of neurodegeneration continues despite managing IOP in some patients. This suggests the existence of and the need to explore additional mechanisms that may contribute to disease progression. Interferon beta (IFNβ), an immunomodulator has been used quite effectively in the management of neurodegenerative conditions, hence its role in glaucoma is worthy of investigation.
